Sign in
Taking people in United StatesNo phase

Searching for genes linked to how severe 22q11.2 deletion syndrome becomes

Studies genes tied to severity in 22q11.2 deletion syndrome patients.

Key facts

Who runs it
Albert Einstein College of Medicine
Where
New York, United StatesSee the site
Trial code
Registry title
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Status
Recruiting
People taking part
1,000 people, planned
Started
Jul 2016
Expected to end
Jun 2029
Type of study
Observational
Record updated
29 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with 22q11.2 deletion syndrome (also called DiGeorge syndrome). It will study their DNA to find genetic changes linked to how severe the disorder is.

Sex
All sexes can join.
Disease stage
22q11.2 deletion syndrome with a deletion of 3 megabases (Mb).
Biomarker or test result
A 22q11 deletion of 3 megabases (Mb).

Main reasons for not taking part

  • A 22q11 deletion smaller than 3 Mb
  • No 22q11 deletion

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Has 22q11 deletion of 3 megabases (Mb)

Who cannot take part

  • Has 22q11 deletion smaller than 3 Mb or no deletion

Where in United States

  • Albert Einstein College Of MedicineNew York, United StatesContact: Bernice E. Morrow, PhD (principal investigator)Taking people

About the trial

What the trial wants to find out

22q11.2 deletion syndrome is a genetic disorder that can cause heart defects, facial abnormalities, and developmental and learning disabilities. The severity of the disorder can vary widely among people. This study will analyze DNA from people with 22q11.2 deletion syndrome to identify genetic variations that may affect the severity of the disorder.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Genetic Modifiers of 22q11.2 Deletion Syndrome
Plain-language title
Searching for genes linked to how severe 22q11.2 deletion syndrome becomesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
29 July 2026